These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 32459282)
1. Resistant starch supplementation effects on plasma indole 3-acetic acid and aryl hydrocarbon receptor mRNA expression in hemodialysis patients: Randomized, double blind and controlled clinical trial. Azevedo R; Esgalhado M; Kemp JA; Regis B; Cardozo LF; Nakao LS; Brito JS; Mafra D J Bras Nefrol; 2020; 42(3):273-279. PubMed ID: 32459282 [TBL] [Abstract][Full Text] [Related]
2. Aryl Hydrocarbon Receptor and Uremic Toxins from the Gut Microbiota in Chronic Kidney Disease Patients: Is There a Relationship between Them? Brito JS; Borges NA; Anjos JSD; Nakao LS; Stockler-Pinto MB; Paiva BR; Cardoso-Weide LC; Cardozo LFMF; Mafra D Biochemistry; 2019 Apr; 58(15):2054-2060. PubMed ID: 30912928 [TBL] [Abstract][Full Text] [Related]
3. Resistant starch type-2 enriched cookies modulate uremic toxins and inflammation in hemodialysis patients: a randomized, double-blind, crossover and placebo-controlled trial. Esgalhado M; Kemp JA; Paiva BR; Brito JS; Cardozo LFMF; Azevedo R; Cunha DB; Nakao LS; Mafra D Food Funct; 2020 Mar; 11(3):2617-2625. PubMed ID: 32159187 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of tissue factor induction by the uremic toxin indole-3 acetic acid through aryl hydrocarbon receptor/nuclear factor-kappa B signaling pathway in human endothelial cells. Addi T; Poitevin S; McKay N; El Mecherfi KE; Kheroua O; Jourde-Chiche N; de Macedo A; Gondouin B; Cerini C; Brunet P; Dignat-George F; Burtey S; Dou L Arch Toxicol; 2019 Jan; 93(1):121-136. PubMed ID: 30324315 [TBL] [Abstract][Full Text] [Related]
5. Could resistant starch supplementation improve inflammatory and oxidative stress biomarkers and uremic toxins levels in hemodialysis patients? A pilot randomized controlled trial. Esgalhado M; Kemp JA; Azevedo R; Paiva BR; Stockler-Pinto MB; Dolenga CJ; Borges NA; Nakao LS; Mafra D Food Funct; 2018 Dec; 9(12):6508-6516. PubMed ID: 30468238 [TBL] [Abstract][Full Text] [Related]
6. Can curcumin supplementation reduce plasma levels of gut-derived uremic toxins in hemodialysis patients? A pilot randomized, double-blind, controlled study. Salarolli RT; Alvarenga L; Cardozo LFMF; Teixeira KTR; de S G Moreira L; Lima JD; Rodrigues SD; Nakao LS; Fouque D; Mafra D Int Urol Nephrol; 2021 Jun; 53(6):1231-1238. PubMed ID: 33438085 [TBL] [Abstract][Full Text] [Related]
7. Can Resveratrol Supplementation Reduce Uremic Toxin Plasma Levels From the Gut Microbiota in Nondialyzed Patients With Chronic Kidney Disease? Alvarenga L; Cardozo LFMF; Leal VO; Kemp JA; Saldanha JF; Ribeiro-Alves M; Meireles T; Nakao LS; Mafra D J Ren Nutr; 2022 Nov; 32(6):685-691. PubMed ID: 35122992 [TBL] [Abstract][Full Text] [Related]
8. Effect of cranberry supplementation on toxins produced by the gut microbiota in chronic kidney disease patients: A pilot randomized placebo-controlled trial. Teixeira KTR; Moreira LSG; Borges NA; Brum I; de Paiva BR; Alvarenga L; Nakao LS; Leal VO; Carraro-Eduardo JC; Rodrigues SD; Lima JD; Ribeiro-Alves M; Mafra D Clin Nutr ESPEN; 2022 Feb; 47():63-69. PubMed ID: 35063244 [TBL] [Abstract][Full Text] [Related]
9. Resistant Starch Type-2 Supplementation Does Not Decrease Trimethylamine N-Oxide (TMAO) Plasma Level in Hemodialysis Patients. Kemp JA; Dos Santos HF; de Jesus HE; Esgalhado M; de Paiva BR; Azevedo R; Stenvinkel P; Bergman P; Lindholm B; Ribeiro-Alves M; Mafra D J Am Nutr Assoc; 2022; 41(8):788-795. PubMed ID: 35512757 [TBL] [Abstract][Full Text] [Related]
10. The effects of 16-weeks of prebiotic supplementation and aerobic exercise training on inflammatory markers, oxidative stress, uremic toxins, and the microbiota in pre-dialysis kidney patients: a randomized controlled trial-protocol paper. Headley SA; Chapman DJ; Germain MJ; Evans EE; Hutchinson J; Madsen KL; Ikizler TA; Miele EM; Kirton K; O'Neill E; Cornelius A; Martin B; Nindl B; Vaziri ND BMC Nephrol; 2020 Nov; 21(1):517. PubMed ID: 33243160 [TBL] [Abstract][Full Text] [Related]
11. The Impact of Enriched Resistant Starch Type-2 Cookies on the Gut Microbiome in Hemodialysis Patients: A Randomized Controlled Trial. Kemp JA; Regis de Paiva B; Fragoso Dos Santos H; Emiliano de Jesus H; Craven H; Z Ijaz U; Alvarenga Borges N; G Shiels P; Mafra D Mol Nutr Food Res; 2021 Oct; 65(19):e2100374. PubMed ID: 34390604 [TBL] [Abstract][Full Text] [Related]
12. Resistant starch supplementation attenuates inflammation in hemodialysis patients: a pilot study. de Paiva BR; Esgalhado M; Borges NA; Kemp JA; Alves G; Leite PEC; Macedo R; Cardozo LFMF; de Brito JS; Mafra D Int Urol Nephrol; 2020 Mar; 52(3):549-555. PubMed ID: 32008198 [TBL] [Abstract][Full Text] [Related]
13. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001 [TBL] [Abstract][Full Text] [Related]
14. Effect of Unripe Banana Flour on Gut-Derived Uremic Toxins in Individuals Undergoing Peritoneal Dialysis: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial. de Andrade LS; Sardá FAH; Pereira NBF; Teixeira RR; Rodrigues SD; de Lima JD; Dalboni MA; Aoike DT; Nakao LS; Cuppari L Nutrients; 2021 Feb; 13(2):. PubMed ID: 33671166 [TBL] [Abstract][Full Text] [Related]
15. Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway. Gondouin B; Cerini C; Dou L; Sallée M; Duval-Sabatier A; Pletinck A; Calaf R; Lacroix R; Jourde-Chiche N; Poitevin S; Arnaud L; Vanholder R; Brunet P; Dignat-George F; Burtey S Kidney Int; 2013 Oct; 84(4):733-44. PubMed ID: 23636172 [TBL] [Abstract][Full Text] [Related]
16. Can curcumin supplementation break the vicious cycle of inflammation, oxidative stress, and uremia in patients undergoing peritoneal dialysis? Reis DCMV; Alvarenga L; Cardozo LFMF; Baptista BG; Fanton S; Paiva BR; Ribeiro-Alves M; Fortunato RS; Vasconcelos AL; Nakao LS; Sanz CL; Berretta AA; Leite M; Mafra D Clin Nutr ESPEN; 2024 Feb; 59():96-106. PubMed ID: 38220413 [TBL] [Abstract][Full Text] [Related]
17. Gut microbiota metabolite indole-3-acetic acid maintains intestinal epithelial homeostasis through mucin sulfation. Li M; Ding Y; Wei J; Dong Y; Wang J; Dai X; Yan J; Chu F; Zhang K; Meng F; Ma J; Zhong W; Wang B; Gao Y; Yang R; Liu X; Su X; Cao H Gut Microbes; 2024; 16(1):2377576. PubMed ID: 39068517 [TBL] [Abstract][Full Text] [Related]
18. Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins. Brito JS; Borges NA; Esgalhado M; Magliano DC; Soulage CO; Mafra D Nephron; 2017; 137(1):1-7. PubMed ID: 28490014 [TBL] [Abstract][Full Text] [Related]
19. Impact of curcumin supplementation on expression of inflammatory transcription factors in hemodialysis patients: A pilot randomized, double-blind, controlled study. Alvarenga L; Salarolli R; Cardozo LFMF; Santos RS; de Brito JS; Kemp JA; Reis D; de Paiva BR; Stenvinkel P; Lindholm B; Fouque D; Mafra D Clin Nutr; 2020 Dec; 39(12):3594-3600. PubMed ID: 32204978 [TBL] [Abstract][Full Text] [Related]
20. A randomized double-blind cross-over trial to study the effects of resistant starch prebiotic in chronic kidney disease (ReSPECKD). Shamloo M; Mollard R; Wang H; Kingra K; Tangri N; MacKay D Trials; 2022 Jan; 23(1):72. PubMed ID: 35073986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]